Mesotherapy: myth and reality

    April 2011 in “Expert Review of Dermatology
    Fatima Al Faresi, Hassan Galadari
    Image of study
    TLDR Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.
    The document from 2011 critically reviews mesotherapy, a procedure involving injections of substance mixtures for fat dissolution, skin rejuvenation, and alopecia treatment. It points out the absence of large, randomized controlled trials to validate the efficacy and safety of mesotherapy, with most data coming from single case reports and small series. The ingredients in mesotherapy, which are not FDA-approved for subcutaneous use, vary and lack transparency in concentration disclosure. Specifically, phosphatidylcholine, the main ingredient purported to dissolve fat, has not been proven effective in trials. The document also mentions that while some studies suggest mesotherapy may improve skin texture, they lack long-term follow-up, and there are no controlled studies confirming its effectiveness for alopecia, with some reports of treatment-induced alopecia. The authors highlight the occurrence of side effects such as infections, allergic reactions, and granulomatous inflammation, and advise extreme caution in the practice of mesotherapy due to these risks and the lack of supporting evidence. They call for controlled trials to establish the safety and benefits of mesotherapy and suggest that future regulations should be based on scientific evidence.
    View this study on tandfonline.com →

    Cited in this study

    Related